Strategic Investment Advisors Horizon Therapeutics Public LTD CO Transaction History

Strategic Investment Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $16,753 - $24,551	-211 Reduced 2.06%	10,044 $801,000
Q1 2022 Apr 28, 2022	BUY	$86.42 - $109.81 $2,074 - $2,635	24 Added 0.23%	10,255 $1.08 Million
Q4 2021 Jan 26, 2022	BUY	$98.56 - $119.91 $19,514 - $23,742	198 Added 1.97%	10,231 $1.1 Million
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $60,109 - $72,181	654 Added 6.97%	10,033 $1.1 Million
Q2 2021 Jul 22, 2021	BUY	$86.24 - $95.92 $319,950 - $355,863	3,710 Added 65.44%	9,379 $878,000
Q1 2021 Apr 14, 2021	BUY	$71.83 - $95.48 $407,204 - $541,276	5,669 New	5,669 $522,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Advisors with notifications on news.